Breaking News, Collaborations & Alliances

Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact   

To create US-APAC manufacturing corridor, enabling local production for global clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Andelyn Biosciences, a cell and gene therapy CDMO, and ENCell Co., Ltd., a Korea-based biopharmaceutical CDMO, signed a collaboration agreement to establish a strategic manufacturing bridge between the U.S. and Asia-Pacific (APAC) regions to help accelerate the global delivery of gene therapies. The partnership leverages both companies’ GMP manufacturing facilities, technical expertise, and extensive regional networks to help fast-track the development, manufacturing, and global expansion of ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters